Logical Therapeutics, a Waltham, MA-based developer of drugs to treat inflammation, says that Peter Lankau has been named CEO of the company, according to a press release. Lankau was previously CEO of Endo Pharmaceuticals (NASDAQ:[[ticker:ENDP]]), a specialty drug firm headquartered in Chadds Ford, PA. Rebecca caught up the Logical in late 2007 and detailed how Logical plans to develop a new compound that turns into anti-inflammation drug naproxen in the bloodstream.
Author: Ryan McBride
Ryan is an award-winning business journalist who contributes to our life sciences and technology coverage. He was previously a staff writer for Mass High Tech, a Boston business and technology newspaper, where he and his colleagues won a national business journalism award from the Society of American Business Editors and Writers in 2008. In recent years, he has made regular TV appearances on New England Cable News.
Prior to MHT, Ryan covered the life sciences, technology, and energy sectors for Providence Business News. He graduated with honors from the University of Rhode Island in 2001 with a bachelor’s degree in communications. When he’s not chasing down news, Ryan enjoys mountain biking and skiing in his home state of Vermont.
View all posts by Ryan McBride
